The Middle East And Africa animal healthcare market is primarily engaged in manufacturing and distributing animal healthcare products such as pharmaceuticals, vaccines, feed additives, performance enhancers, diagnostic kits and medical devices to prevent and treat animal diseases. Geographically, the animal healthcare industry caters majorly to farm animals such as cattle, poultry, swine and companion animals including dogs and cats. The advent of livestock farming for dairy, eggs and meat production is resulting in increased cases of animal ailments which is promoting greater utilization of medications and vaccines. Additionally, pet adoption has emerged as a trend across affluent households in the Middle East & Africa region coupled with rising consciousness about animal well-being which is boosting expenditure on healthcare facilities for companion animals.
The Global Middle East And Africa Animal Healthcare Market is estimated to be valued at US$ 5478.77 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the Middle East And Africa animal healthcare are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co.
The growing demand for animal protein along with increasing animal adoption is expected to drive the Middle East And Africa animal healthcare market during the forecast period. With rising meat consumption in countries such as Saudi Arabia, Iran, Egypt, and South Africa, the demand for veterinary healthcare services and products is increasing.
Furthermore, key players are focusing on expanding their presence across different countries in the Middle East and African region to leverage growth opportunities. Favorable governmental support along with increasing pet care expenditure is encouraging multinational companies to broaden their geographic footprint in countries like UAE, Nigeria, and Kenya over the next few years.
Market drivers
One of the major drivers for the Middle East And Africa Animal Healthcare Market Size is rising livestock population. Countries in the Middle Eastern and African regions have witnessed a surge in the numbers of cattle, poultry and swine breeding over the past decade to satisfy the demand for animal proteins. However, overcrowding on farms increases the risk of disease outbreaks which is propelling the need for veterinary medical supplies and medicine for prevention as well as treatment of livestock illnesses. This rising dependency on the animal healthcare industry for farm animals is expected to significantly boost the regional market during the forecast period.
The current geopolitical situation in the Middle East and Africa region is impacting the growth of the animal healthcare market in various ways. The ongoing conflicts and political instability in several Middle Eastern countries like Syria, Yemen, Libya etc. has negatively impacted the veterinary infrastructure and provision of animal healthcare services in those nations. Resources that could have been allocated for development of the veterinary sector have been diverted to deal with emergencies arising due to conflicts. This has restricted the growth potential of the animal healthcare market there.
Moreover, movement of livestock and veterinary professionals across borders has become difficult due to security issues, reducing collaboration between nations on animal disease management and control. Cross-border transmission of transboundary diseases have increased. However, growing awareness about economic losses due to diseases and rising demand for protein is prompting governments as well as private organizations to formulate strategies for strengthening veterinary facilities and services even in conflict-afflicted areas.
Vaccination programs for major diseases are being expanded while establishing fresh networks of community-based animal health workers. Telemedicine and digital platforms are helping address the challenges posed by conflicts to some extent. Going forward, efforts must be made to ensure uninterrupted supply of essential drugs and diagnostics, support regional research on livestock diseases through collaborations, and build resilience of veterinary infrastructure in vulnerable areas. This can help sustain the growth momentum of the animal healthcare market in the region despite geopolitical headwinds.
The Middle East and Africa animal healthcare market is concentrated highly in the Gulf countries in terms of value, led by Saudi Arabia. Being one of the largest producers and exporters of livestock and livestock products, the Kingdom invests significantly towards animal disease prevention and control. It has a well-developed veterinary service network and robust regulations to ensure safety of locally produced as well as imported animal food products. Other lucrative Gulf markets include the UAE and Qatar while Egypt contributes notably due to its large cattle and poultry populations.
Meanwhile, the animal healthcare market in Africa is witnessing fastest growth in Ethiopia where livestock rearing plays a vital socio-economic role. Supported by government initiatives and external funding, Ethiopia is expanding veterinary infrastructure especially in pastoralist areas. It has intensified control programs against major diseases of cattle, shoep and goats that are crucial for millions of livelihoods and food security in the nation. Growing at a double-digit CAGR, the East African country is emerging as a market to look out for in the forecast period.
Get more insights on- Middle East And Africa Animal Healthcare Market